The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes

[1]  E. Bertini,et al.  Expanding the clinical phenotype of CAPN1-associated mutations: A new case with congenital-onset pure spastic paraplegia , 2017, Journal of the Neurological Sciences.

[2]  K. Amunts,et al.  Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia , 2017, Brain : a journal of neurology.

[3]  Sepp Hochreiter,et al.  panelcn.MOPS: Copy‐number detection in targeted NGS panel data for clinical diagnostics , 2017, Human mutation.

[4]  R. Schüle,et al.  Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways , 2017, Movement disorders : official journal of the Movement Disorder Society.

[5]  M. Cowley,et al.  Defining the genetic basis of early onset hereditary spastic paraplegia using whole genome sequencing , 2016, neurogenetics.

[6]  E. Bertini,et al.  Congenital-onset spastic paraplegia in a patient with TUBB4A mutation and mild hypomyelination , 2016, Journal of Neurological Sciences.

[7]  P. Seeman,et al.  SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia , 2016, Journal of Human Genetics.

[8]  A. Singleton,et al.  Genetic and phenotypic characterization of complex hereditary spastic paraplegia , 2016, Brain : a journal of neurology.

[9]  A. Vanderver,et al.  Diffuse hypomyelination is not obligate for POLR3-related disorders , 2016, Neurology.

[10]  H. Houlden,et al.  Hereditary Spastic Paraplegia in Greece: Characterisation of a previously unexplored population using next generation sequencing , 2015, European Journal of Human Genetics.

[11]  S. Klebe,et al.  Hereditary Spastic Paraplegia -clinico-genetic lessons from 608 patients: Key Concepts in Hereditary Spastic Paraplegia , 2016 .

[12]  L. Kalaydjieva,et al.  Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia , 2015, Movement disorders : official journal of the Movement Disorder Society.

[13]  P. Sham,et al.  PMCA4 (ATP2B4) mutation in familial spastic paraplegia causes delay in intracellular calcium extrusion , 2015, Brain and behavior.

[14]  F. Santorelli,et al.  Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms , 2014, Experimental Neurology.

[15]  Y. Crow,et al.  Mutations in ADAR1, IFIH1, and RNASEH2B Presenting As Spastic Paraplegia , 2014, Neuropediatrics.

[16]  P. Sham,et al.  PMCA4 (ATP2B4) Mutation in Familial Spastic Paraplegia , 2014, PloS one.

[17]  A. Munnich,et al.  A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1 , 2013, Journal of Medical Genetics.

[18]  Z. Al-Hassnan,et al.  A novel splice site mutation in ERLIN2 causes hereditary spastic paraplegia in a Saudi family. , 2013, European journal of medical genetics.

[19]  F. Al-Mohanna,et al.  Loss of ERLIN2 function leads to juvenile primary lateral sclerosis , 2012, Annals of neurology.

[20]  J. Zaremba,et al.  Screening for the hereditary spastic paraplaegias SPG4 and SPG3A with the multiplex ligation-dependent probe amplification technique in a large population of affected individuals , 2013, Neurological Sciences.

[21]  F. Alkuraya,et al.  A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18) , 2011, neurogenetics.

[22]  M. Battaglini,et al.  Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI , 2011, Journal of Neurology.

[23]  A. Bentivoglio,et al.  Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early‐onset levodopa‐responsive Parkinsonism , 2011, Movement disorders : official journal of the Movement Disorder Society.

[24]  G. Cioni,et al.  Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia , 2011, European journal of neurology.

[25]  W. O'Brien,et al.  Novel human pathological mutations. Gene symbol: ASS1. Disease: Citrullinaemia. , 2009, Human Genetics.

[26]  A. Berardelli,et al.  Four novel SPG3A/atlastin mutations identified in autosomal dominant hereditary spastic paraplegia kindreds with intra‐familial variability in age of onset and complex phenotype , 2009, Clinical genetics.

[27]  E. Bertini,et al.  Screening of ARHSP‐TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion , 2009, Human mutation.

[28]  F. Baldinotti,et al.  Novel human pathological mutations. Gene symbol: SPG4. Disease: spastic paraplegia, autosomal dominant. , 2009, Human Genetics.

[29]  M. Hua,et al.  Mutations of the SPG11 gene in patients with autosomal recessive spastic paraparesis and thin corpus callosum , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[30]  J. Winkler,et al.  Long‐term course and mutational spectrum of spatacsin‐linked spastic paraplegia , 2007, Annals of neurology.

[31]  O. Witte,et al.  High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia , 2006, Neurology.

[32]  C. Ponting,et al.  Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.

[33]  Hong Yang,et al.  Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects , 2005, Annals of Neurology.

[34]  M. Ruberg,et al.  Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. , 2004, Archives of neurology.

[35]  J. Weissenbach,et al.  Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. , 2000, Human molecular genetics.